Cronos Group Inc. shareholders elected all seven director nominees and approved executive compensation and auditor appointments at the 2026 Annual Meeting of Shareholders held on June 18, 2026. Shareholders holding 271,828,759 common shares, representing 72.24% of the total outstanding shares, voted in person or by proxy.

Each director nominee received in excess of 93.6% of the votes cast. Michael Gorenstein received 93.67% of the votes, while Jason Adler and Darren Broughton each received 99.42%. The detailed voting results for the election of directors are as follows:

Shareholders approved an advisory resolution on the compensation of the Company’s named executive officers, with 99.09% of votes cast in favor. They also voted in favor of holding future advisory votes on executive compensation every year.

Davidson & Company LLP was appointed as the independent auditor for fiscal year 2026. The Board of Directors was authorized to fix the independent auditor's remuneration.

Complete results are available on the Company’s SEDAR+ profile and Form 8-K filed with the SEC.

Cronos Group Inc. has expanded its share repurchase program to include the Toronto Stock Exchange (TSX) and other alternative Canadian trading systems, following the acceptance of its notice of intention by the exchange. The program, initially approved by the Board on May 8, 2026, allows Cronos to buy back up to US$50 million of its common shares for cancellation. This initiative aims to return capital to shareholders and is expected to run until May 13, 2027, unless terminated earlier.

Under the TSX normal course issuer bid (NCIB), Cronos may purchase up to 53,968 common shares on any trading day, representing 25% of the average daily trading volume of 215,873 shares for the six months ended May 31, 2026. Purchases under the TSX NCIB are set to commence on June 19, 2026. Celadon Financial Group, LLC has been appointed as the company's agent to execute repurchases, with Virtu Canada Corp. handling transactions on Canadian facilities.

The repurchase program is subject to a maximum of 18,712,918 common shares, which constitutes approximately 5.02% of Cronos' 373 million issued and outstanding shares as of June 1, 2026. The company may also repurchase shares through the Nasdaq Global Market, other U.S. published markets, and privately negotiated transactions, as previously announced.

On June 15, 2026, Cronos secured an exemption order from the Ontario Securities Commission, permitting repurchases on U.S. marketplaces in excess of limits typically imposed by Canadian securities laws. The exemption allows Cronos to buy back up to the greater of 5% of its outstanding shares or 10% of its public float, provided aggregate repurchases across all marketplaces do not exceed this amount during the approximately 11-month period of the TSX NCIB.

The TSX NCIB will be conducted in accordance with TSX rules and policies, with purchase prices determined by prevailing market rates or other permitted prices. Further details regarding the NCIB Exemption will be disclosed in Cronos' quarterly report on Form 10-Q for the quarter ended June 30, 2026.

Key Details of the Share Repurchase Program